Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT03455517 · COMPLETED
Trial details
- NCT number
- NCT03455517
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2021-09-05
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.